ALS 과거 수익 실적

과거 기준 확인 0/6

ALS의 수입은 연평균 -0.2%의 비율로 감소해 온 반면, Professional Services 산업은 수입이 연평균 14.6%의 비율로 증가했습니다. 매출은 연평균 8.8%의 비율로 증가해 왔습니다. ALS의 자기자본이익률은 0.8%이고 순이익률은 0.2%입니다.

주요 정보

-0.2%

수익 성장률

-0.2%

EPS 성장률

Professional Services 산업 성장	14.5%
매출 성장률	8.8%
자기자본 수익률	0.8%
순이익	0.2%
다음 실적 업데이트	27 May 2025

최근 과거 실적 업데이트

Recent updates

수익 및 비용 분석

ALS 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

DB:CP4 수익, 비용 및 수입 (AUD Millions )
날짜	수익	수익	G+A 비용
30 Sep 24	2,703	6	137
30 Jun 24	2,582	10	137
31 Mar 24	2,462	13	137
31 Dec 23	2,420	138	135
30 Sep 23	2,379	264	133
30 Jun 23	2,329	270	133
31 Mar 23	2,279	275	133
30 Sep 22	2,051	260	110
30 Jun 22	2,002	225	110
31 Mar 22	1,952	190	110
31 Dec 21	2,023	183	105
30 Sep 21	1,946	176	99
30 Jun 21	1,854	173	99
31 Mar 21	1,761	170	99
31 Dec 20	1,768	113	95
30 Sep 20	1,774	57	91
30 Jun 20	1,814	67	91
31 Mar 20	1,854	76	91
31 Dec 19	1,806	122	105
30 Sep 19	1,758	167	119
30 Jun 19	1,711	167	119
31 Mar 19	1,665	167	119
31 Dec 18	1,611	159	114
30 Sep 18	1,556	150	110
30 Jun 18	1,502	108	110
31 Mar 18	1,447	66	110
31 Dec 17	1,398	57	103
30 Sep 17	1,348	48	97
30 Jun 17	1,305	75	97
31 Mar 17	1,262	102	97
30 Sep 16	1,157	-230	-324
30 Jun 16	1,198	-230	-113
31 Mar 16	1,239	-230	99
31 Dec 15	1,394	-208	753
30 Sep 15	1,424	-176	747
30 Jun 15	1,423	-175	785
31 Mar 15	1,422	-173	824
31 Dec 14	1,416	-29	897
30 Sep 14	1,410	115	970
30 Jun 14	1,397	134	954
31 Mar 14	1,384	153	937

양질의 수익: CP4 에는 A$292.1M 큰 일회성 손실이 있습니다. A$292.1M 은 지난 12개월 간의 재무 결과에 30th September, 2024 까지 영향을 미쳤습니다.

이익 마진 증가: CP4 의 현재 순이익 이익률 (0.2%) 작년보다 낮습니다 (11.1%).

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: CP4 의 수입은 지난 5년 동안 매년 0.2% 씩 감소했습니다.

성장 가속화: CP4 은(는) 지난 1년 동안 마이너스 수익 성장을 기록했기 때문에 5년 평균과 비교할 수 없습니다.

수익 대 산업: CP4 은 지난 1년 동안 마이너스 수익 성장( -97.7% )을 기록하여 Professional Services 업계 평균( -2.1% ).

ALS 과거 수익 실적

과거 기준 확인 0/6

주요 정보

최근 과거 실적 업데이트

ALS Limited to Report Fiscal Year 2025 Results on May 27, 2025

Full year 2024 earnings released: EPS: AU$0.027 (vs AU$0.57 in FY 2023)

ALS Limited to Report Fiscal Year 2024 Results on May 21, 2024

Full year 2023 earnings released: EPS: AU$0.57 (vs AU$0.39 in FY 2022)

First half 2023 earnings released: EPS: AU$0.30 (vs AU$0.15 in 1H 2022)

ALS Limited to Report Fiscal Year 2023 Results on May 24, 2023

Recent updates

Now 21% overvalued

Now 20% overvalued

ALS Limited Appoints Dayna Field as General Counsel and Company Secretary, Effective 1 October 2024

ALS Limited Announces Resignation of Michael Pearson as Company Secretary & General Counsel

ALS Limited to Report Fiscal Year 2025 Results on May 27, 2025

Final dividend of AU$0.039 announced

New minor risk - Earnings quality

Full year 2024 earnings released: EPS: AU$0.027 (vs AU$0.57 in FY 2023)

ALS Limited (ASX:ALQ) agreed to acquire Wessling Holding Gmbh & Co.Kg.

Now 20% undervalued after recent price drop

Now 20% undervalued

ALS Limited, Annual General Meeting, Jul 31, 2024

ALS Limited Appoints Stuart Hutton as Chief Financial Officer, Effective 1 February 2024

Investor sentiment improves as stock rises 19%

ALS Limited Announces Stepdown of Luis Damasceno as Chief Financial Officer, Effective 19 January 2024

ALS Limited Appoints Heike Truöl as Chief Strategy Officer

ALS Limited to Report Fiscal Year 2024 Results on May 21, 2024

Independent Chairman recently bought €364k worth of stock

ALS Limited Announces Board Changes

Upcoming dividend of AU$0.19 per share at 3.4% yield

ALS Limited Declares Final Dividend for the Fiscal Year 2023, Payable on 6 July 2023

Full year 2023 earnings released: EPS: AU$0.57 (vs AU$0.39 in FY 2022)

ALS Limited Appoints Malcolm Deane as Managing Director

Insufficient new directors

Upcoming dividend of AU$0.20 per share

First half 2023 earnings released: EPS: AU$0.30 (vs AU$0.15 in 1H 2022)

ALS Limited Declares an Unfranked Interim Dividend for the First Half of Fiscal Year 2023, Payable on 16 December 2022

ALS Limited Appoints Peter Possemiers as an Independent Non-Executive Director Effective 1 November 2022

ALS Limited Declares Final Dividend

ALS Limited (ASX:ALQ) announces an Equity Buyback for 9,000,000 shares, representing 1.86% for AUD 100 million.

ALS Limited to Report Fiscal Year 2023 Results on May 24, 2023

ALS Limited (ASX:ALQ) made an non-binding indicative offer to acquire HRL Holdings Limited (ASX:HRL) for AUD 79 million.

ALS Limited (ASX:ALQ) made an non-binding indicative offer to acquire HRL Holdings Limited (ASX:HRL) for AUD 79 million.

Independent Non-Executive Director recently bought €59k worth of stock

Independent Non-Executive Director recently bought €59k worth of stock

Upcoming dividend of AU$0.17 per share

Full year 2022 earnings released: EPS: AU$0.40 (vs AU$0.36 in FY 2021)

ALS Limited Declares Dividend for the Period Ended March 31, 2022, Payable on July 4, 2022

ALS Limited Declares Dividend for the Period Ended March 31, 2022, Payable on July 4, 2022

ALS Limited to Report First Half, 2023 Results on Nov 14, 2022

Insufficient new directors

Investor sentiment improved over the past week

Insufficient new directors

ALS Limited (ASX:ALQ) agreed to acquire MinAnalytical Laboratory Services Pty Ltd. from Perenti Global Limited (ASX:PRN) for AUD 39 million.

Upcoming dividend of AU$0.16 per share

First half 2022 earnings released: EPS AU$0.15 (vs AU$0.14 in 1H 2021)

Independent Non-Executive Director recently bought €73k worth of stock

Investor sentiment improved over the past week

Upcoming dividend of AU$0.15 per share

Full year 2021 earnings released: EPS AU$0.36 (vs AU$0.16 in FY 2020)

ALS Limited Declares Final Dividend, payable on July 5, 2021

ALS Limited (ASX:ALQ) entered in an agreement to acquire Investiga.

New 90-day high: €6.90

New 90-day high: €6.45

ALS Limited to Report Fiscal Year 2021 Final Results on Jun 23, 2021

First half 2021 earnings released: EPS AU$0.15

ALS Limited, Annual General Meeting, Jul 28, 2021

Revenue misses expectations

ALS Limited to Report Fiscal Year 2021 Results on May 26, 2021

New 90-day high: €6.00

New 90-day high: €5.80

New 90-day high: €5.75

New 90-day high - €5.50

New 90-day high - €5.40

New 90-day high - €4.58

수익 및 비용 분석

수익 및 매출 내역

잉여현금흐름 대 수익 분석

과거 수익 성장 분석